STING1 and cancer: Despite acute activation of cGAS/STING provides undoubted benefits against pathogens and cancer cells, a chronic activation may result in an IFN-driven systemic inflammation, inducing a cytokine storm [103] (cytokine release syndrome [104]), similarly to sepsis.